Associate Professor of Medicine, Georgetown University

Infectious Disease

Princy Kumar is an expert in the field of Infectious Disease. She has 5 awards "America's Top Doctors", "Top Doctors:Washington DC Area", "Top Doctors:Washington-Baltimore", "Meaningful Use Stage 1 Certification" and "Top MD". Princy Kumar is a published doctor and has 14 publications published. The lastest was: 'Resistant cytomegalovirus in intestinal and multivisceral transplant recipients.' She is registered with Medicare.

Publications

---

• Resistant cytomegalovirus in intestinal and multivisceral transplant recipients.
• Periodic Lateralized Epileptiform Discharges (PLEDs) in Patients With Neurosyphilis and HIV Infection.
• Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine.
• Pharmacologic Issues of Antiretroviral Agents and Immunosuppressive Regimens in HIV-infected Solid Organ Transplant Recipients.
• Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
• Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.
• Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-week Results from the REALMRK Study.
• Serious infection from Staphylococcus aureus in 2 HIV-infected patients receiving fusion inhibitor therapy.
• Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy.
• Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 ...
• Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 re...
• Lamivudine for the treatment of HIV.
• A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zid...

Schools

---

• Georgetown University

• Englewood Hospital and Med Center

Doctors Specialties

---

• Infectious Disease Medicine
• Infectious Disease

Accepted Insurances

---

Awards

---

• America's Top Doctors
• Top Doctors:Washington DC Area
• Top Doctors:Washington-Baltimore
• Meaningful Use Stage 1 Certification
• Top MD

Education

---

• Georgetown University Hospital

Hospital

---

• MedStar Georgetown University Hospital

Drug Facts

---

NPI NUMBER		1790784957
NPPES Provider LastName		KUMAR
NPPES Provider FirstName		PRINCY
NPPES Provider ZIPCode		200072113
NPPES Provider State		DC
Specialty Description		Infectious Disease
Total Claim Count		336.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1790784957
Last Name Of The Provider	KUMAR
First Name Of The Provider	PRINCY
View All

Similar Doctors

---

	Dr. Namrata P. Shah, MD
	Dr. Laura Coster, MD This Doctor is OpenDoctor Recommended.
	Dr. Itzhak Brook, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Aaron M. Perlmutter, MD This Doctor is OpenDoctor Recommended.
	Dr. Bernardine S. Mohanraj, MD This Doctor is OpenDoctor Recommended.
	Dr. Adam Sherwat, MD
	Dr. Jesse L. Goodman, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph G. Jemsek, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Shilpa Marwaha, MD This Doctor is OpenDoctor Recommended.
	Dr. Seble Kassaye, MD This Doctor is OpenDoctor Recommended.
	Dr. Jhansi L. Gajjala, MD This Doctor is OpenDoctor Recommended.
	Dr. Larissa L. Stabinski, MD
	Dr. Robert A. Delapenha, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Emily J. Erbelding, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog